{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:49:48Z","timestamp":1789487388838,"version":"build-2803163510"},"reference-count":40,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"unspecified","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"\u00d8stifterne","award":["2022-0006"],"award-info":[{"award-number":["2022-0006"]}]},{"name":"Sygesikring Danmark","award":["2021-0020"],"award-info":[{"award-number":["2021-0020"]}]},{"DOI":"10.13039\/501100018940","name":"Diabetesforeningen","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100018940","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2026,9,1]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Targeted type 2 diabetes screening campaigns aim to improve patients\u2019 quality of life and life expectancy and reduce healthcare costs, although different setups may yield varying detection outcomes. The aim of this study is to assess whether at-home self-sampling improves the detection rates of prediabetes and diabetes compared with standard mobile unit screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods<\/jats:title>\n                    <jats:p>Between June 2022 and November 2024, the Danish Diabetes Association offered free capillary HbA1c tests to individuals at high risk of diabetes based on the Leicester\u2019s Risk Assessment score. Two community-based screening setups were applied: (a) a mobile unit using a point-of-care device and (b) at-home self-sampling screening tests using mailed Hemoglobin Capillary Collection System analyzed by high-performance liquid chromatography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 4051 individuals were tested via the mobile unit and 5609 via the at-home setup. In the mobile unit setup, the proportion of individuals aged \u226565 years was 54.3%, whereas in the at-home setup, they constituted 38.1%. HbA1c \u226548 mmol\/mol (\u22656.5%) was found in 3.1% of participants in the mobile unit and 3.5% in the at-home setup, while HbA1c values of 42\u201347 mmol\/mol (6.0\u20136.4%) occurred in 9.1% and 15.2%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Mobile units and at-home self-sampling are complementary screening approaches, finding similar rates of screen detection with HbA1c \u226548 mmol\/mol (\u22656.5%), though the latter is more efficient in detecting individuals with HbA1c values of 42\u201347 mmol\/mol (6.0\u20136.4%).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2026-006034","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:00:52Z","timestamp":1789480852000},"page":"e006034","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Differences in screen-detected type 2 diabetes in two targeted community-based screening campaigns in Denmark"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9125-947X","authenticated-orcid":false,"given":"Nuri Cayuelas","family":"Mateu","sequence":"first","affiliation":[{"name":"Diabetesforeningen, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1531-4294","authenticated-orcid":false,"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicin, University of Copenhagen, Copenhagen, Denmark"},{"name":"Steno Diabetes Center Copenhaguen, Gentofte, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten Piepgras","family":"Neergaard","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhaguen, Gentofte, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5448-1208","authenticated-orcid":false,"given":"Tanja","family":"Thybo","sequence":"additional","affiliation":[{"name":"Diabetesforeningen, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"2026091507003874000_14.5.e006034.1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.2007.S21"},{"key":"2026091507003874000_14.5.e006034.2","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2459"},{"key":"2026091507003874000_14.5.e006034.3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/1403494818799606","article-title":"Estimates of prediabetes and undiagnosed type 2 diabetes in Denmark: The end of an epidemic or a diagnostic artefact?","volume":"48","author":"J\u00f8rgensen","year":"2020","journal-title":"Scand J Public Health"},{"key":"2026091507003874000_14.5.e006034.4","unstructured":"International Diabetes Federation . IDF diabetes atlas. 10th edn. Brussels, Belgium: International Diabetes Federation, 2021."},{"key":"2026091507003874000_14.5.e006034.5","unstructured":"Diabetestal.nu. Denmark. 2026 Available: https:\/\/www.diabetestal.nu"},{"key":"2026091507003874000_14.5.e006034.6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jdiacomp.2017.09.010","article-title":"Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort","volume":"32","author":"Gedebjerg","year":"2018","journal-title":"J Diabetes Complications"},{"key":"2026091507003874000_14.5.e006034.7","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2020.1787971"},{"key":"2026091507003874000_14.5.e006034.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-016-4065-6"},{"key":"2026091507003874000_14.5.e006034.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4299-y"},{"key":"2026091507003874000_14.5.e006034.10","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1007\/s00125-017-4397-x","article-title":"Should we screen for type 2 diabetes among asymptomatic individuals? Yes","volume":"60","author":"Simmons","year":"2017","journal-title":"Diabetologia"},{"key":"2026091507003874000_14.5.e006034.11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ecl.2021.05.002","article-title":"Screening for Diabetes and Prediabetes","volume":"50","author":"Duan","year":"2021","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2026091507003874000_14.5.e006034.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61422-6"},{"key":"2026091507003874000_14.5.e006034.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62162-0"},{"key":"2026091507003874000_14.5.e006034.14","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1007\/s00125-017-4402-4","article-title":"Screening for type 2 diabetes: do screen-detected cases fare better?","volume":"60","author":"Feldman","year":"2017","journal-title":"Diabetologia"},{"key":"2026091507003874000_14.5.e006034.15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135702","article-title":"Systematic Review and Meta-Analysis of Response Rates and Diagnostic Yield of Screening for Type 2 Diabetes and Those at High Risk of Diabetes","volume":"10","author":"Khunti","year":"2015","journal-title":"PLoS One"},{"key":"2026091507003874000_14.5.e006034.16","unstructured":"World Health Organization . Screening for type 2 diabetes: report of a world health organization and international diabetes federation meeting. Geneva World Health Organization; 2003. Available: http:\/\/www.who.int\/diabetes\/publications\/en\/screening_mnc03.pdf"},{"key":"2026091507003874000_14.5.e006034.17","unstructured":"Stinton C , Mansbridge A , Williams H , et al . What is the effect of population-level screening of asymptomatic adults for type 2 diabetes mellitus or intermediate hyperglycaemia on health outcomes. WHO Health Evidence Network (HEN) synthesis report 79. Copenhagen WHO Regional Office for Europe; 2024. Available: https:\/\/iris.who.int\/bitstream\/handle\/10665\/378077\/9789289061087-eng.pdf"},{"key":"2026091507003874000_14.5.e006034.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2010.03056.x"},{"key":"2026091507003874000_14.5.e006034.19","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2147\/CLEP.S469958","article-title":"The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Project Cohort and Biobank from 2010 Through 2023-A Cohort Profile Update","volume":"16","author":"Kristensen","year":"2024","journal-title":"Clin Epidemiol"},{"key":"2026091507003874000_14.5.e006034.20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-048846","article-title":"Tingbjerg Changing Diabetes: a protocol for a long-term Supersetting initiative to promote health and prevent type 2 diabetes among people living in an ethnically and socioeconomically diverse neighbourhood in Copenhagen, Denmark","volume":"11","author":"T\u00f8rslev","year":"2021","journal-title":"BMJ Open"},{"key":"2026091507003874000_14.5.e006034.21","article-title":"Danish community pharmacies supporting self-care for patients","volume":"12","author":"Hansen","year":"2023","journal-title":"Explor Res Clin Soc Pharm"},{"key":"2026091507003874000_14.5.e006034.22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055764","article-title":"Characteristics of participants who take up screening tests for diabetes and lipid disorders: a systematic review","volume":"12","author":"Ding","year":"2022","journal-title":"BMJ Open"},{"key":"2026091507003874000_14.5.e006034.23","article-title":"Disparities in adherence to diabetes screening guidelines among males and females in a universal care setting: A population-based study of 1,380,697 adults","volume":"14","author":"Kaul","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"2026091507003874000_14.5.e006034.24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2025-005539","article-title":"Feasibility and cost-effectiveness of at-home self-sampling screening for type 2 diabetes: a pilot screening study in Denmark","volume":"14","author":"Mateu","year":"2026","journal-title":"BMJ Open Diab Res Care"},{"key":"2026091507003874000_14.5.e006034.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2010.03037.x"},{"key":"2026091507003874000_14.5.e006034.26","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/dme.13433","article-title":"External national validation of the Leicester Self\u2010Assessment score for Type 2 diabetes using data from the English Longitudinal Study of Ageing","volume":"34","author":"Barber","year":"2017","journal-title":"Diabet Med"},{"key":"2026091507003874000_14.5.e006034.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2017.08.005"},{"key":"2026091507003874000_14.5.e006034.28","doi-asserted-by":"publisher","DOI":"10.2337\/dci23-0040"},{"key":"2026091507003874000_14.5.e006034.29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/clinchem\/hvaf059","article-title":"Challenges in Hb A1c Point-of-Care Testing: Only 5 of 19 Hb A1c Point-of-Care Devices Meet IFCC and NGSP Certification Criteria on Independent Evaluation","volume":"71","author":"Lenters-Westra","year":"2025","journal-title":"Clin Chem"},{"key":"2026091507003874000_14.5.e006034.30","unstructured":"Tosoh Corporation . Brochure HLC-723G11 Variant. Tosoh Automated Glycohemoglobin Analyzer Variant Analysis Mode. Tokyo: Tosoh Corporation; 2025. Available: https:\/\/www.scribd.com\/document\/563795995\/Brochure-HLC-723G11-Variant"},{"key":"2026091507003874000_14.5.e006034.31","doi-asserted-by":"crossref","DOI":"10.1080\/16549716.2020.1795439","article-title":"Early detection of type 2 diabetes in socioeconomically disadvantaged areas in Stockholm - comparing reach of community and facility-based screening","volume":"13","author":"Timm","year":"2020","journal-title":"Glob Health Action"},{"key":"2026091507003874000_14.5.e006034.32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2337\/cd23-0020","article-title":"Community-Based Diabetes Awareness Strategy With Detection and Intervention: The Mobile Diabetes Education Center","volume":"42","author":"Shubrook","year":"2024","journal-title":"Clin Diabetes"},{"key":"2026091507003874000_14.5.e006034.33","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae044","article-title":"Clinical and Metabolic Characterization of Women With Gestational Diabetes Mellitus Within the First Year Postpartum","volume":"8","author":"Knudsen","year":"2024","journal-title":"J Endocr Soc"},{"key":"2026091507003874000_14.5.e006034.34","doi-asserted-by":"crossref","first-page":"e2196","DOI":"10.1210\/clinem\/dgae113","article-title":"Type 2 Diabetes Risk After Gestational Diabetes According to Country\/Region of Origin: A Nationwide Register-based Study","volume":"109","author":"Nielsen","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091507003874000_14.5.e006034.35","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det469"},{"key":"2026091507003874000_14.5.e006034.36","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/humrep\/deae124","article-title":"Prospective risk of Type 2 diabetes in 99 892 Nordic women with polycystic ovary syndrome and 446 055 controls: national cohort study from Denmark, Finland, and Sweden","volume":"39","author":"Glintborg","year":"2024","journal-title":"Hum Reprod"},{"key":"2026091507003874000_14.5.e006034.37","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/S0140-6736(25)01067-0","article-title":"Managing early-onset type 2 diabetes in the individual and at the population level","volume":"405","author":"Misra","year":"2025","journal-title":"Lancet"},{"key":"2026091507003874000_14.5.e006034.38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.amepre.2014.05.012","article-title":"Reconsidering the age thresholds for type II diabetes screening in the U.S","volume":"47","author":"Chung","year":"2014","journal-title":"Am J Prev Med"},{"key":"2026091507003874000_14.5.e006034.39","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-S011"},{"key":"2026091507003874000_14.5.e006034.40","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.pcd.2019.05.007","article-title":"HbA1c-testing: Evaluation of two point-of-care analysers","volume":"13","author":"Dubach","year":"2019","journal-title":"Prim Care Diabetes"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2026-006034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:00:58Z","timestamp":1789480858000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2026-006034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9,15]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bmjdrc-2026-006034"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2026-006034","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}